4.5 Review

Why is melanoma so metastatic?

期刊

PIGMENT CELL & MELANOMA RESEARCH
卷 27, 期 1, 页码 -

出版社

WILEY
DOI: 10.1111/pcmr.12172

关键词

metastasis; angiogenesis; mesenchymal phenotype; stemness; mutations profile

向作者/读者索取更多资源

Malignant melanoma is one of the most aggressive cancers and can disseminate from a relatively small primary tumor and metastasize to multiple sites, including the lung, liver, brain, bone, and lymph nodes. Elucidating the molecular and genetic changes that take place during the metastatic process has led to a better understanding of why melanoma is so metastatic. Herein, we describe the unique features that distinguish melanoma from other solid tumors and contribute to the malignant phenotype of melanoma cells. For example, although melanoma cells are highly antigenic, they are extremely efficient at evading host immune response. Melanoma cells share numerous cell surface molecules with vascular cells, are highly angiogenic, are mesenchymal in nature, and possess a higher degree of stemness' than do other solid tumors. Finally, analysis of melanoma mutations has revealed that the gene expression profile of malignant melanoma is different from that of other cancers. Elucidating these molecular and genetic processes in highly metastatic melanoma can lead to the development of improved treatment and individualized therapy options.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

C3a elicits unique migratory responses in immature low-density neutrophils

Brian E. Hsu, Joannie Roy, Jack Mouhanna, Roni F. Rayes, LeeAnn Ramsay, Sebastien Tabaries, Matthew G. Annis, Ian R. Watson, Jonathan D. Spicer, Santiago Costantino, Peter M. Siegel

ONCOGENE (2020)

Article Oncology

Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

Pingping Hou, Avnish Kapoor, Qiang Zhang, Jiexi Li, Chang-Jiun Wu, Jun Li, Zhengdao Lan, Ming Tang, Xingdi Ma, Jeffrey J. Ackroyd, Raghu Kalluri, Jianhua Zhang, Shan Jiang, Denise J. Spring, Y. Alan Wang, Ronald A. DePinho

CANCER DISCOVERY (2020)

Article Oncology

Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition

Tatiana Shorstova, Jie Su, Tiejun Zhao, Michael Dahabieh, Matthew Leibovitch, Mariana De Sa Tavares Russo, Daina Avizonis, Shivshankari Rajkumar, Ian R. Watson, Sonia del Rincon, Wilson H. Miller, William D. Foulkes, Michael Witcher

Summary: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and often lethal cancer diagnosed at a median age of 24 years. Current treatment options are limited, but a combination therapy of BET inhibitor OTX015 and MEK inhibitor cobimetinib has shown promising results in repressing the proliferation of SCCOHT in vivo. This synergy is also observed in some SMARCA4-expressing ovarian adenocarcinoma models, indicating potential for a rational combination therapy against SCCOHT and potentially other ovarian cancer subtypes.

MOLECULAR CANCER THERAPEUTICS (2021)

Article Cell Biology

USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer

Pingping Hou, Xingdi Ma, Zecheng Yang, Qiang Zhang, Chang-Jiun Wu, Jun Li, Lin Tan, Wantong Yao, Liang Yan, Xin Zhou, Alec C. Kimmelman, Philip L. Lorenzi, Jianhua Zhang, Shan Jiang, Denise Spring, Y. Alan Wang, Ronald A. DePinho

Summary: The study uncovers USP21 as a driver of KRAS*-independent PDAC growth by inducing macropinocytosis, which maintains intracellular amino acid levels. USP21 may play a role in affecting responsiveness to emergent anti-KRAS* therapy.

GENES & DEVELOPMENT (2021)

Article Multidisciplinary Sciences

Telomere dysfunction instigates inflammation in inflammatory bowel disease

Deepavali Chakravarti, Rumi Lee, Asha S. Multani, Andrea Santoni, Zachery Keith, Wen-Hao Hsu, Kyle Chang, Laura Reyes, Asif Rashid, Chang-Jiun Wu, Jun Li, Jiexin Zhang, Hong Seok Shim, Krishna Chandra, Pingna Deng, Denise J. Spring, Ole Haagen Nielsen, Lene Buhl Riis, Kavya Kelagere Mayigegowda, Sarah E. Blutt, Jianhua Zhang, Mamoun Younes, Andrew DuPont, Selvi Thirumurthi, Eduardo Vilar, Mary K. Estes, Simona Colla, Noah F. Shroyer, Ronald A. DePinho

Summary: The study explores the role of the ATM/YAP1/pro-IL-18 pathway in the pathogenesis of inflammatory bowel disease (IBD), particularly in older-onset cases. Telomere dysfunction in intestinal epithelium may initiate the inflammatory process in IBD, suggesting new therapeutic interventions for the disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Cell Biology

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

Christopher J. Terranova, Ming Tang, Mayinuer Maitituoheti, Ayush T. Raman, Archit K. Ghosh, Jonathan Schulz, Samir B. Amin, Elias Orouji, Katarzyna Tomczak, Sharmistha Sarkar, Junna Oba, Caitlin Creasy, Chang-Jiun Wu, Samia Khan, Rossana Lazcano, Khalida Wani, Anand Singh, Praveen Barrodia, Dongyu Zhao, Kaifu Chen, Lauren E. Haydu, Wei-Lien Wang, Alexander J. Lazar, Scott E. Woodman, Chantale Bernatchez, Kunal Rai

Summary: The dynamic changes in chromatin state patterns during metastasis, particularly in NRAS mutant melanoma, is associated with the reprogramming of bivalent domains and broad domains. Pharmacological inhibition of EZH2 can decrease invasive capacity of melanoma cells and reduce tumor burden, while also increasing the expression of specific genes related to metastasis. This suggests a potential therapeutic strategy for NRAS mutant melanoma patients.

CELL REPORTS (2021)

Article Oncology

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Marcelo Negrao, Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bara, Vincent Shen, Hao Xu, Sylvia Hu, Dawen Sui, Yasir Y. Elamin, Xiuning Le, Michael E. Goldberg, Karthikeyan Murugesan, Chang-Jiun Wu, Jianhua Zhang, David S. Barreto, Jacqulyne P. Robichaux, Alexandre Reuben, Tina Cascone, Carl M. Gay, Kyle G. Mitchell, Lingzhi Hong, Waree Rinsurongkawong, Jack A. Roth, Stephen G. Swisher, Jack Lee, Anne Tsao, Vassiliki Papadimitrakopoulou, Don L. Gibbons, Bonnie S. Glisson, Gaurav Singal, Vincent A. Miller, Brian Alexander, Garrett Frampton, Lee A. Albacker, David Shames, Jianjun Zhang, John Heymach

Summary: High TMB and PD-L1 expression are predictive for benefit from ICB treatment in oncogene-driven NSCLCs. NSCLC harboring BRAF mutations demonstrated superior benefit from ICB that may be attributed to higher TMB and higher PD-L1 expression in these tumors.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Multidisciplinary Sciences

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

Ming Chen, Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jiexin Zhang, Junya Fujimoto, Shawna M. Hubert, Carl M. Gay, Bo Zhu, Yanhua Tian, Nicholas McGranahan, Won-Chul Lee, Julie George, Xiao Hu, Yamei Chen, Meijuan Wu, Carmen Behrens, Chi-Wan Chow, Hoa H. N. Pham, Junya Fukuoka, Jia Wu, Edwin Roger Parra, Latasha D. Little, Curtis Gumbs, Xingzhi Song, Chang-Jiun Wu, Lixia Diao, Qi Wang, Robert Cardnell, Jianhua Zhang, Jing Wang, Xiuning Le, Don L. Gibbons, John Heymach, J. Jack Lee, William N. William, Chao Cheng, Bonnie Glisson, Ignacio Wistuba, P. Andrew Futreal, Roman K. Thomas, Alexandre Reuben, Lauren A. Byers, Jianjun Zhang

Summary: In this study, researchers found that limited-stage small-cell lung cancer (LS-SCLC) tumors have a relatively homogeneous mutational landscape but a cold and heterogeneous TCR repertoire. Higher mutational burden, higher T cell infiltration, and positive PD-L1 expression are associated with longer overall survival, while higher chromosomal copy number aberration (CNA) burden is associated with shorter overall survival in patients with LS-SCLC.

NATURE COMMUNICATIONS (2021)

Article Oncology

Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer

Rumi Lee, Jiexi Li, Jun Li, Chang-Jiun Wu, Shan Jiang, Wen-Hao Hsu, Deepavali Chakravarti, Peiwen Chen, Kyle A. LaBella, Jing Li, Denise J. Spring, Di Zhao, Y. Alan Wang, Ronald A. DePinho

Summary: This study identifies critical effectors in the maintenance of APC-deficient colorectal cancer and demonstrates the relationship between APC/WNT pathway and kynurenine pathway signaling. It further determines the tumor-associated macrophage biology in APC-deficient colorectal cancer, informing genotype-specific therapeutic targets and the use of TDO2 inhibitors.

CANCER DISCOVERY (2022)

Article Multidisciplinary Sciences

Multi-modal molecular programs regulate melanoma cell state

Miles C. Andrews, Junna Oba, Chang-Jiun Wu, Haifeng Zhu, Tatiana Karpinets, Caitlin A. Creasy, Marie-Andree Forget, Xiaoxing Yu, Xingzhi Song, Xizeng Mao, A. Gordon Robertson, Gabriele Romano, Peng Li, Elizabeth M. Burton, Yiling Lu, Robert Szczepaniak Sloane, Khalida M. Wani, Kunal Rai, Alexander J. Lazar, Lauren E. Haydu, Matias A. Bustos, Jianjun Shen, Yueping Chen, Margaret B. Morgan, Jennifer A. Wargo, Lawrence N. Kwong, Cara L. Haymaker, Elizabeth A. Grimm, Patrick Hwu, Dave S. B. Hoon, Jianhua Zhang, Jeffrey E. Gershenwald, Michael A. Davies, P. Andrew Futreal, Chantale Bernatchez, Scott E. Woodman

Summary: The regulation of distinct intrinsic phenotypic states in melanoma involves complex molecular mechanisms, which are associated with immune features within tumors and have differential correlations with immunotherapy efficacy. These findings have significant implications for cancer biology and the development of new therapeutic strategies.

NATURE COMMUNICATIONS (2022)

Article Oncology

Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer

Pat Gulhati, Aislyn Schalck, Shan Jiang, Xiaoying Shang, Chang-Jiun Wu, Pingping Hou, Sharia Hernandez Ruiz, Luisa Solis Soto, Edwin Parra, Haoqiang Ying, Jincheng Han, Prasenjit Dey, Jun Li, Pingna Deng, Emi Sei, Dean Y. Maeda, John A. Zebala, Denise J. Spring, Michael Kim, Huamin Wang, Anirban Maitra, Dirk Moore, Karen Clise-Dwyer, Y. Alan Wang, Nicholas E. Navin, Ronald A. DePinho

Summary: Pancreatic ductal adenocarcinoma (PDAC) is resistant to PD1 and CTLA4 immune checkpoint therapies. This study characterized the mechanisms of ICT resistance and identified effective therapeutic options. The combination of agonist 41BB and antagonist LAG3 ICT increased survival and antitumor immunity. Triple therapy with T cell-activating ICTs and a CXCR1/2 inhibitor resulted in durable complete responses. This provides a testable hypothesis for clinical testing in human PDAC.

NATURE CANCER (2023)

Article Cell Biology

Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer's disease models

Hong Seok Shim, James W. Horner, Chang-Jiun Wu, Jiexi Li, Zheng D. Lan, Shan Jiang, Xueping Xu, Wen-Hao Hsu, Tomasz Zal, Ivonne I. Flores, Pingna Deng, Yuan-Ta Lin, Li-Huei Tsai, Y. Alan Wang, Ronald A. DePinho

Summary: The research found that deficiency of telomerase reverse transcriptase (TERT) affects neuronal expression and accumulation of amyloid-beta in the brain, while maintaining normal levels of TERT helps reduce amyloid-beta accumulation and preserve cognitive function. Furthermore, the interaction between TERT, beta-catenin, and RNA polymerase II at gene promoters leads to the upregulation of gene networks governing synaptic signaling and learning processes.

NATURE AGING (2021)

Meeting Abstract Oncology

Seeing glycolysis on PDAC: Applying deep learning convolutional neural network model

Peiling Tsou, Chang-Jiun Wu

CANCER RESEARCH (2020)

Article Oncology

Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanoma

Rached Alkallas, Mathieu Lajoie, Dan Moldoveanu, Karen Vo Hoang, Philippe Lefrancois, Marine Lingrand, Mozhdeh Ahanfeshar-Adams, Kevin Watters, Alan Spatz, Jonathan H. Zippin, Hamed S. Najafabadi, Ian R. Watson

NATURE CANCER (2020)

Article Oncology

p66ShcA functions as a contextual promoter of breast cancer metastasis

Kyle Lewis, Alex Kiepas, Jesse Hudson, Julien Senecal, Jacqueline R. Ha, Elena Voorand, Matthew G. Annis, Valerie Sabourin, Ryuhjin Ahn, Rachel La Selva, Sebastien Tabaries, Brian E. Hsu, Matthew J. Siegel, Matthew Dankner, Eduardo Cepeda Canedo, Mathieu Lajoie, Ian R. Watson, Claire M. Brown, Peter M. Siegel, Josie Ursini-Siegel

BREAST CANCER RESEARCH (2020)

暂无数据